Insight Folios’s Idexx Laboratories IDXX Stock Holding History

Insight Folios’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-400	Closed	-$222K	–	123
2023 Q4	$222K	Buy	+400	New	+$188K	0.1%	109
2022 Q1	–	Sell	-333	Closed	-$219K	–	129
2021 Q4	$219K	Buy	+333	New	+$209K	0.1%	129

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Insight Folios's IDXX Position: Q1 2024 in Review

Insight Folios sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 400 shares — an estimated $222K sold.

Insight Folios first reported a position in IDXX in Q4 2021 and held it in 2 quarters. The position peaked at $222K in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Insight Folios reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Insight Folios sold 400 Idexx Laboratories shares in Q1 2024, an estimated $222K.
Insight Folios first reported a position in Idexx Laboratories in Q4 2021 and held it in 2 quarters.
Insight Folios's Idexx Laboratories position peaked at $222K in Q4 2023.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Insight Folios's 13F filing for Q1 2024, filed 19 Apr 2024.